MATERIALS AND METHODS A literature search was performed using PubMed, Scopus, Medline, Embase and Cochrane databases
This injectable treatment is generally recommended for individuals with a BMI of 30 or higher or those with a BMI of 27 or higher who also have weight-related health conditions such as type 2 diabetes or hypertension
Several key factors play a significant role in how quickly and effectively tirzepatide kicks in and the overall trajectory of your weight loss journey
Finding support on your GLP-1 journey The foods GLP-1 users discuss most are not always the ones you might predict, and that gap between expectation and reality is part of what makes these online communities so valuable
Its best to work with your doctor on a gradual taper rather than stopping abruptly
Which drug is considered more effective for weight loss based on clinical evidence: Wegovy : 10-15% average weight loss over 68 weeks Ozempic (diabetes dosing): 5-10% average weight loss Ozempic (off-label higher dosing): Similar to Wegovy results Mounjaro : 15-22% average weight loss over 72 weeks Which is better Wegovy or Ozempic for weight loss clearly favors Wegovy when used at approved dosing